ReviewFrontiers in endocrinology2025

Sodium-glucose transporter 2 inhibitors and cardiovascular-kidney-metabolic syndrome: a narrative review.

Yuqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.